Intact (S/N1806) Phase Iii Randomized Trial Of Concurrent Chemoradiotherapy With Or Without Atezolizumab In Localized Muscle-Invasive Bladder Cancer: Safety Update On First 73 Patients.

Parminder Singh, Jason A. Efstathiou,Catherine Tangen,Sameer G. Jhavar,Noah M. Hahn,Brian Addis Costello,Scott Edward Delacroix,Abhishek Tripathi,Sean Sachdev,Jessie Gills,Ashesh B. Jani,Rick Bangs,Melissa Plets,Nicholas J. Vogelzang,Ian Murchie Thompson,Felix Y Feng,Seth P. Lerner

JOURNAL OF CLINICAL ONCOLOGY（2021）

引用 12|浏览9

暂无评分

摘要

428Background: Trimodality therapy (TMT) with maximal TURBT followed by chemoradiation(CRT) is a standard of care for select patients with muscle invasive bladder cancer (MIBC). This trial evaluate...

查看译文

关键词

Atezolizumab,Bladder cancer,Randomized controlled trial,Urology,Medicine,Concurrent chemoradiotherapy,Muscle invasive,Standard of care

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要